S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
Check Out This 6-Year Win Streak (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
Want Diversified Upside in Biotechnology? Check out LABU
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
Check Out This 6-Year Win Streak (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
Want Diversified Upside in Biotechnology? Check out LABU
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
Check Out This 6-Year Win Streak (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
Want Diversified Upside in Biotechnology? Check out LABU
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
Check Out This 6-Year Win Streak (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
Want Diversified Upside in Biotechnology? Check out LABU
NYSE:CC

Chemours - CC Stock Forecast, Price & News

$29.18
-0.74 (-2.47%)
(As of 03/22/2023 12:00 AM ET)
Add
Compare
Today's Range
$29.16
$30.29
50-Day Range
$28.57
$36.73
52-Week Range
$23.58
$44.95
Volume
810,044 shs
Average Volume
1.11 million shs
Market Capitalization
$4.34 billion
P/E Ratio
8.17
Dividend Yield
3.43%
Price Target
$36.33

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
24.5% Upside
$36.33 Price Target
Short Interest
Bearish
3.07% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.37mentions of Chemours in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$983,087 Sold Last Quarter
Proj. Earnings Growth
23.21%
From $3.92 to $4.83 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.78 out of 5 stars

Basic Materials Sector

26th out of 159 stocks

Chemicals & Allied Products Industry

4th out of 15 stocks


CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

How Better Chemistry Catalyzes Decarbonization
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Chemours: How Black History Can Shape the Future of STEM
Chemours (CC) Posts Break-Even Q4 Earnings, Sales Miss
Chemours (CC) Q4 2022 Earnings Call Transcript
Chemours (NYSE:CC) Will Pay A Dividend Of $0.25
Chemours (CC) Reports Break-Even Earnings for Q4
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Last Earnings
11/04/2021
Ex-Dividend for 3/15 Dividend
2/23/2023
Dividend Payable
3/15/2023
Today
3/22/2023
Next Earnings (Estimated)
5/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$36.33
High Stock Price Forecast
$43.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+24.5%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
10 Analysts

Profitability

Net Income
$578 million
Pretax Margin
10.91%

Debt

Sales & Book Value

Annual Sales
$6.79 billion
Cash Flow
$7.00 per share
Book Value
$7.34 per share

Miscellaneous

Free Float
146,379,000
Market Cap
$4.34 billion
Optionable
Optionable
Beta
1.88

Key Executives

  • Mark E. NewmanMark E. Newman
    President, Chief Executive Officer & Director
  • Sameer RalhanSameer Ralhan
    Chief Financial Officer & Senior Vice President
  • Kristine Wellman
    Secretary, Senior Vice President & General Counsel
  • Camela T. Wisel
    Chief Accounting Officer, VP & Controller
  • Alisha BellezzaAlisha Bellezza
    President-Thermal & Specialized Solutions













CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price forecast for 2023?

10 analysts have issued twelve-month target prices for Chemours' shares. Their CC share price forecasts range from $27.00 to $43.00. On average, they expect the company's share price to reach $36.33 in the next year. This suggests a possible upside of 24.5% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2023?

Chemours' stock was trading at $30.62 on January 1st, 2023. Since then, CC shares have decreased by 4.7% and is now trading at $29.18.
View the best growth stocks for 2023 here
.

Are investors shorting Chemours?

Chemours saw a increase in short interest in February. As of February 28th, there was short interest totaling 4,480,000 shares, an increase of 7.7% from the February 13th total of 4,160,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 4.2 days. Currently, 3.1% of the company's stock are sold short.
View Chemours' Short Interest
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our CC earnings forecast
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) posted its earnings results on Thursday, November, 4th. The specialty chemicals company reported $1.27 EPS for the quarter, topping analysts' consensus estimates of $0.99 by $0.28. The specialty chemicals company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.58 billion. Chemours had a trailing twelve-month return on equity of 61.75% and a net margin of 8.51%. The company's revenue for the quarter was up 36.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.47 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Monday, February 6th. Stockholders of record on Friday, February 24th will be given a dividend of $0.25 per share on Wednesday, March 15th. This represents a $1.00 dividend on an annualized basis and a yield of 3.43%. The ex-dividend date is Thursday, February 23rd.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.49%. The dividend payout ratio is 28.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 20.70% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CC.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY23 earnings guidance on Thursday, February, 9th. The company provided earnings per share guidance of $3.80-4.29 for the period, compared to the consensus earnings per share estimate of $4.06.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include LSV Asset Management (1.96%), JPMorgan Chase & Co. (1.91%), Dimensional Fund Advisors LP (1.55%), Geode Capital Management LLC (1.38%), AQR Capital Management LLC (1.13%) and Norges Bank (1.02%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $29.18.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $4.34 billion and generates $6.79 billion in revenue each year. The specialty chemicals company earns $578 million in net income (profit) each year or $3.57 on an earnings per share basis.

How many employees does Chemours have?

The company employs 6,600 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 3/23/2023 by MarketBeat.com Staff